Innate Pharma IPHA
NASDAQ IPHA
$1.69 +0.09 (+5.63%)
As of: Sep 30, 2026 · 1:42 PM EDT

Innate Pharma SA (IPHA) Net Margin (2020 - 2025)

Updated

Innate Pharma (IPHA) posted Net Margin of -378284.62% for the quarter ended Dec 31, 2025, up 71451.75 percentage points from -449736.36% a year earlier.

Analysis

Innate Pharma SA (IPHA) Net Margin (2020 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Innate Pharma's Net Margin came in at -546.11%, down 300.24 percentage points from the prior year.

  • Annual Net Margin shows a five-year change of -454.40 percentage points (years ended Dec 2020 to Dec 2025).
  • In prior years, Innate Pharma's Net Margin was -245.87% in the year ended Dec 31, 2024 (-233.59 pp), -12.28% in the year ended Dec 31, 2023 (+88.46 pp), -100.74% in the year ended Dec 31, 2022 (+113.03 pp) and -213.78% in the year ended Dec 31, 2021 (-122.07 pp).
  • The figure for the quarter ended Dec 31, 2025 stands as the highest quarterly Net Margin since the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -378,284.62%
Dec 31, 2024 -449,736.36%
Dec 31, 2023 -68,818.18%
Dec 31, 2022 -98.48%
Dec 31, 2020 -9,437.17%
API Access

Innate Pharma SA Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IPHA&period=max&api_key=YOUR_API_KEY